Search Results - "Gich Saladich, Ignasi J."

Survival in Mediterranean Ambulatory Patients With Chronic Heart Failure. A Population-based Study by Frigola-Capell, Eva, Comin-Colet, Josep, Davins-Miralles, Josep, Gich-Saladich, Ignasi J., Wensing, Michel, Verdú-Rotellar, Jose M.

“…Scarce research has been performed in ambulatory patients with chronic heart failure in the Mediterranean area. Our aim was to describe survival trends in our…”
Get full text

Supervivencia de pacientes ambulatorios con insuficiencia cardiaca crónica del área mediterránea. Un estudio de base poblacional by Frigola-Capell, Eva, Comin-Colet, Josep, Davins-Miralles, Josep, Gich-Saladich, Ignasi J, Wensing, Michel, Verdú-Rotellar, Jose M

“…Resumen Introducción y objetivos La investigación realizada en pacientes ambulatorios con insuficiencia cardiaca crónica en el área mediterránea es escasa…”
Get full text

Overall survival, quality of life and magnitude of clinical benefit of breast cancer drugs over the last 25 years by Tapia, J. Carlos, Bujosa Rodríguez, Aida, Molto, Consolacion, Templeton, Arnoud J., Shepshelovich, Daniel, Goldvaser, Hadar, Gich Saladich, Ignasi J., Barnadas, Agusti, Amir, Eitan, Tibau, Ariadna

“…Abstract only 6571 Background: The American Society of Clinical Oncology Cancer Research Committee (ASCO-CRC), the ASCO Value Framework Net Health Benefit…”
Get full text

Factors associated with change in the magnitude of clinical benefit of anti-cancer drugs in the post-marketing period by Bujosa Rodríguez, Aida, Molto, Consolacion, Hwang, Thomas J, Vokinger, Kerstin Noëlle, Tapia, Jose Carlos, Gich Saladich, Ignasi J., Templeton, Arnoud J., Barnadas, Agusti, Amir, Eitan, Tibau, Ariadna

“…Abstract only 7052 Background: Initial drug approval is often based on surrogate endpoints. Definitive outcomes like Overall Survival (OS) or Quality of life…”
Get full text

Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration by Molto, Consolacion, Hwang, Thomas J., Andres, Marta, Borrell, Maria, Gich Saladich, Ignasi J., Barnadas, Agust, Amir, Eitan, Kesselheim, Aaron S., Tibau Martorell, Ariadna

“…Abstract only 6513 Background: The Breakthrough Therapy program was established in July 2012 to expedite drug development and approval by the FDA. We compared…”
Get full text

Influence of comorbidities on pain intensity in patients with chronic low back pain by Melo Cruz, Martha Cristina, Santeularia Verges, Maria Teresa, Rius Llorens, Carme, Gich Saladich, Ignasi J., Català Puigbó, Elena

Get full text